CAYMAN CHEMICAL COMPANY Non-Antibody Products — page 3 of 649
Non-Antibody Products
Page 3 of 649
| Name | Description | Size | Catalog # | |
|---|---|---|---|---|
| AAL-993 | A potent inhibitor of VEGF receptors, inhibiting VEGFR1, 2, and 3 with IC5… | 1 mg | 16351-1 | More Info |
| AAL-993 | A potent inhibitor of VEGF receptors, inhibiting VEGFR1, 2, and 3 with IC5… | 5 mg | 16351-5 | More Info |
| (9,10a)-anti-Δ6a,7-THC | An analytical reference standard that is structurally similar to known phy… | 1 mg | 37046-1 | More Info |
| (9,10a)-anti-Δ6a,7-THC | An analytical reference standard that is structurally similar to known phy… | 5 mg | 37046-5 | More Info |
| AAPH | A water-soluble azo compound used extensively as a free radical generator | 10 g | 82235-10 | More Info |
| AAPH | A water-soluble azo compound used extensively as a free radical generator | 5 g | 82235-5 | More Info |
| A2AR Agonist-1 | An agonist of the adenosine A2A receptor and an inhibitor of ENT1 (Kis = 4… | 1 mg | 28414-1 | More Info |
| A2AR Agonist-1 | An agonist of the adenosine A2A receptor and an inhibitor of ENT1 (Kis = 4… | 5 mg | 28414-5 | More Info |
| A2AR Agonist-1 | An agonist of the adenosine A2A receptor and an inhibitor of ENT1 (Kis = 4… | 500 µg | 28414-500 | More Info |
| AAT-008 | An orally bioavailable, potent, and selective EP4 receptor antagonist (IC5… | 1 mg | 21810-1 | More Info |
| AAT-008 | An orally bioavailable, potent, and selective EP4 receptor antagonist (IC5… | 10 mg | 21810-10 | More Info |
| AAT-008 | An orally bioavailable, potent, and selective EP4 receptor antagonist (IC5… | 25 mg | 21810-25 | More Info |
| AAT-008 | An orally bioavailable, potent, and selective EP4 receptor antagonist (IC5… | 5 mg | 21810-5 | More Info |
| AA-T3A-C12 | An ionizable cationic lipidoid; has been used in the generation of LNPs; L… | 1 mg | 38648-1 | More Info |
| AA-T3A-C12 | An ionizable cationic lipidoid; has been used in the generation of LNPs; L… | 10 mg | 38648-10 | More Info |
| AA-T3A-C12 | An ionizable cationic lipidoid; has been used in the generation of LNPs; L… | 5 mg | 38648-5 | More Info |
| A 26771B | A macrolide antibiotic; active against various bacteria (MICs = C. tropica… | 1 mg | 29593-1 | More Info |
| A-54556B | A natural acyldepsipeptide that is effective against Gram-positive bacteri… | 2.5 mg | 17090-25 | More Info |
| A-54556B | A natural acyldepsipeptide that is effective against Gram-positive bacteri… | 500 µg | 17090-500 | More Info |
| AB-005 | A synthetic CB built on a 1-[(1-methylpiperidin-2-yl)methyl]-indole base t… | 1 mg | 11766-1 | More Info |
| AB-005 | A synthetic CB built on a 1-[(1-methylpiperidin-2-yl)methyl]-indole base t… | 10 mg | 11766-10 | More Info |
| AB-005 | A synthetic CB built on a 1-[(1-methylpiperidin-2-yl)methyl]-indole base t… | 5 mg | 11766-5 | More Info |
| AB-680 | An inhibitor of ecto-5'-nucleotidase (IC50 = 0.043 nM in CHO cells express… | 1 mg | 32798-1 | More Info |
| AB-680 | An inhibitor of ecto-5'-nucleotidase (IC50 = 0.043 nM in CHO cells express… | 10 mg | 32798-10 | More Info |
| AB-680 | An inhibitor of ecto-5'-nucleotidase (IC50 = 0.043 nM in CHO cells express… | 25 mg | 32798-25 | More Info |
| AB-680 | An inhibitor of ecto-5'-nucleotidase (IC50 = 0.043 nM in CHO cells express… | 5 mg | 32798-5 | More Info |
| AB-928 | An adenosine A2A and A2B receptor dual antagonist; inhibits the ability of… | 10 mg | 31444-10 | More Info |
| AB-928 | An adenosine A2A and A2B receptor dual antagonist; inhibits the ability of… | 25 mg | 31444-25 | More Info |
| AB-928 | An adenosine A2A and A2B receptor dual antagonist; inhibits the ability of… | 5 mg | 31444-5 | More Info |
| AB-928 | An adenosine A2A and A2B receptor dual antagonist; inhibits the ability of… | 50 mg | 31444-50 | More Info |
| Abacavir | A nucleoside analog and HIV-1 reverse transcriptase inhibitor (Ki = 2.1 &m… | 1 g | 36925-1 | More Info |
| Abacavir | A nucleoside analog and HIV-1 reverse transcriptase inhibitor (Ki = 2.1 &m… | 2.5 g | 36925-25 | More Info |
| Abacavir | A nucleoside analog and HIV-1 reverse transcriptase inhibitor (Ki = 2.1 &m… | 5 g | 36925-5 | More Info |
| Abacavir | A nucleoside analog and HIV-1 reverse transcriptase inhibitor (Ki = 2.1 &m… | 500 mg | 36925-500 | More Info |
| Abacavir Carboxylate | An inactive metabolite of abacavir; formed from abacavir via reactive alde… | 1 mg | 27777-1 | More Info |
| Abacavir-d4 | An internal standard for the quantification of abacavir by GC- or LC-MS | 1 mg | 30076-1 | More Info |
| Abacavir-d4 | An internal standard for the quantification of abacavir by GC- or LC-MS | 500 µg | 30076-500 | More Info |
| Abacavir (sulfate) | A nucleoside analog and HIV-1 reverse transcriptase inhibitor (Ki = 2.1 &m… | 10 mg | 14746-10 | More Info |
| Abacavir (sulfate) | A nucleoside analog and HIV-1 reverse transcriptase inhibitor (Ki = 2.1 &m… | 25 mg | 14746-25 | More Info |
| Abacavir (sulfate) | A nucleoside analog and HIV-1 reverse transcriptase inhibitor (Ki = 2.1 &m… | 5 mg | 14746-5 | More Info |
| Abacavir (sulfate) | A nucleoside analog and HIV-1 reverse transcriptase inhibitor (Ki = 2.1 &m… | 50 mg | 14746-50 | More Info |
| Abafungin | An antifungal agent; active against a variety of dermatophytes, yeast, mol… | 10 mg | 35465-10 | More Info |
| Abafungin | An antifungal agent; active against a variety of dermatophytes, yeast, mol… | 25 mg | 35465-25 | More Info |
| Abafungin | An antifungal agent; active against a variety of dermatophytes, yeast, mol… | 50 mg | 35465-50 | More Info |
| Abaloparatide (acetate) | A synthetic derivative of PTHrP (1-34) and an agonist of PTH1R; selectivel… | 1 mg | 28816-1 | More Info |
| Abaloparatide (acetate) | A synthetic derivative of PTHrP (1-34) and an agonist of PTH1R; selectivel… | 10 mg | 28816-10 | More Info |
| Abaloparatide (acetate) | A synthetic derivative of PTHrP (1-34) and an agonist of PTH1R; selectivel… | 25 mg | 28816-25 | More Info |
| Abaloparatide (acetate) | A synthetic derivative of PTHrP (1-34) and an agonist of PTH1R; selectivel… | 5 mg | 28816-5 | More Info |
| Abamectin | A mixture of the natural macrocyclic lactones avermectin B1a and avermecti… | 100 mg | 19201-100 | More Info |
| Abamectin | A mixture of the natural macrocyclic lactones avermectin B1a and avermecti… | 50 mg | 19201-50 | More Info |
| Abametapir | A building block and an insecticide; has been used in the synthesis of lan… | 1 g | 30684-1 | More Info |
| Abametapir | A building block and an insecticide; has been used in the synthesis of lan… | 10 g | 30684-10 | More Info |
| Abametapir | A building block and an insecticide; has been used in the synthesis of lan… | 25 g | 30684-25 | More Info |
| Abametapir | A building block and an insecticide; has been used in the synthesis of lan… | 5 g | 30684-5 | More Info |
| Abarelix (acetate) | A synthetic GnRHR antagonist (IC50 = 3.5 nM); decreases plasma LH levels s… | 1 mg | 28746-1 | More Info |
| Abarelix (acetate) | A synthetic GnRHR antagonist (IC50 = 3.5 nM); decreases plasma LH levels s… | 10 mg | 28746-10 | More Info |
| Abarelix (acetate) | A synthetic GnRHR antagonist (IC50 = 3.5 nM); decreases plasma LH levels s… | 25 mg | 28746-25 | More Info |
| Abarelix (acetate) | A synthetic GnRHR antagonist (IC50 = 3.5 nM); decreases plasma LH levels s… | 5 mg | 28746-5 | More Info |
| AB-005 azepane isomer | A variant of AB-005 in which the methylpiperidine group has been replaced… | 1 mg | 11877-1 | More Info |
| AB-005 azepane isomer | A variant of AB-005 in which the methylpiperidine group has been replaced… | 10 mg | 11877-10 | More Info |
| AB-005 azepane isomer | A variant of AB-005 in which the methylpiperidine group has been replaced… | 5 mg | 11877-5 | More Info |
| AB-BICA | A synthetic cannabinoid whose physiological and toxicological properties a… | 1 mg | 18759-1 | More Info |
| AB-BICA | A synthetic cannabinoid whose physiological and toxicological properties a… | 5 mg | 18759-5 | More Info |
| AB-5Br-INACA | An analytical reference standard categorized as a precursor in the synthes… | 1 mg | 39953-1 | More Info |
| AB-5Br-INACA | An analytical reference standard categorized as a precursor in the synthes… | 5 mg | 39953-5 | More Info |
| ABBV-075 | A BRD2, BRD4, and BRDT inhibitor; selective over BRD3 and against a panel… | 1 mg | 21033-1 | More Info |
| ABBV-075 | A BRD2, BRD4, and BRDT inhibitor; selective over BRD3 and against a panel… | 10 mg | 21033-10 | More Info |
| ABBV-075 | A BRD2, BRD4, and BRDT inhibitor; selective over BRD3 and against a panel… | 5 mg | 21033-5 | More Info |
| ABBV-075 | A BRD2, BRD4, and BRDT inhibitor; selective over BRD3 and against a panel… | 500 µg | 21033-500 | More Info |
| ABBV-744 | A BD2 bromodomain inhibitor (Kis = 4.6, 4.9, 1.6, and 1 nM for BRD2, -3, -… | 10 mg | 30470-10 | More Info |
| ABBV-744 | A BD2 bromodomain inhibitor (Kis = 4.6, 4.9, 1.6, and 1 nM for BRD2, -3, -… | 25 mg | 30470-25 | More Info |
| ABBV-744 | A BD2 bromodomain inhibitor (Kis = 4.6, 4.9, 1.6, and 1 nM for BRD2, -3, -… | 5 mg | 30470-5 | More Info |
| ABBV-744 | A BD2 bromodomain inhibitor (Kis = 4.6, 4.9, 1.6, and 1 nM for BRD2, -3, -… | 50 mg | 30470-50 | More Info |
| ABBV-CLS-484 (hydrochloride) | An inhibitor of PTP1N and PTP2N (IC50s = 2.5 and 1.8 nM, respectively); se… | 1 mg | 40169-1 | More Info |
| ABBV-CLS-484 (hydrochloride) | An inhibitor of PTP1N and PTP2N (IC50s = 2.5 and 1.8 nM, respectively); se… | 5 mg | 40169-5 | More Info |
| ABC294640 | An inhibitor of SPHK2 (Ki = 9.8 µM); inhibits SPHK2 (IC50 = 60 &micr… | 1 mg | 10587-1 | More Info |
| ABC294640 | An inhibitor of SPHK2 (Ki = 9.8 µM); inhibits SPHK2 (IC50 = 60 &micr… | 10 mg | 10587-10 | More Info |
| ABC294640 | An inhibitor of SPHK2 (Ki = 9.8 µM); inhibits SPHK2 (IC50 = 60 &micr… | 25 mg | 10587-25 | More Info |
| ABC294640 | An inhibitor of SPHK2 (Ki = 9.8 µM); inhibits SPHK2 (IC50 = 60 &micr… | 5 mg | 10587-5 | More Info |
| ABC34 | An inactive control probe for JJH260, an inhibitor of FAHFA hydrolysis | 1 mg | 19385-1 | More Info |
| ABC34 | An inactive control probe for JJH260, an inhibitor of FAHFA hydrolysis | 5 mg | 19385-5 | More Info |
| ABC34 | An inactive control probe for JJH260, an inhibitor of FAHFA hydrolysis | 500 µg | 19385-500 | More Info |
| ABC99 | An NHH carbamate that inhibits the Wnt-deacylating enzyme NOTUM (IC50 = 13… | 1 mg | 25858-1 | More Info |
| ABC99 | An NHH carbamate that inhibits the Wnt-deacylating enzyme NOTUM (IC50 = 13… | 5 mg | 25858-5 | More Info |
| ABC99 | An NHH carbamate that inhibits the Wnt-deacylating enzyme NOTUM (IC50 = 13… | 500 µg | 25858-500 | More Info |
| 3,5-AB-CHMFUPPYCA | An analytical reference standard that is structurally similar to known syn… | 1 mg | 18204-1 | More Info |
| 3,5-AB-CHMFUPPYCA | An analytical reference standard that is structurally similar to known syn… | 5 mg | 18204-5 | More Info |
| 5,3-AB-CHMFUPPYCA | An analytical reference standard that is structurally similar to known syn… | 1 mg | 18296-1 | More Info |
| 5,3-AB-CHMFUPPYCA | An analytical reference standard that is structurally similar to known syn… | 5 mg | 18296-5 | More Info |
| AB-CHMIATA | An analytical reference standard that is structurally similar to known syn… | 1 mg | 38136-1 | More Info |
| AB-CHMIATA | An analytical reference standard that is structurally similar to known syn… | 5 mg | 38136-5 | More Info |
| AB-CHMINACA metabolite M2 | A carboxylic acid metabolite of AB-CHMINACA; intended for forensic and res… | 1 mg | 16389-1 | More Info |
| AB-CHMINACA metabolite M2 | A carboxylic acid metabolite of AB-CHMINACA; intended for forensic and res… | 10 mg | 16389-10 | More Info |
| AB-CHMINACA metabolite M2 | A carboxylic acid metabolite of AB-CHMINACA; intended for forensic and res… | 5 mg | 16389-5 | More Info |
| AB-CHMINACA metabolite M4 | An expected metabolite of AB-CHMINACA in which the carboxamide group has b… | 1 mg | 16393-1 | More Info |
| AB-CHMINACA metabolite M4 | An expected metabolite of AB-CHMINACA in which the carboxamide group has b… | 10 mg | 16393-10 | More Info |
| AB-CHMINACA metabolite M4 | An expected metabolite of AB-CHMINACA in which the carboxamide group has b… | 5 mg | 16393-5 | More Info |
| AB-CHMINACA metabolite M6 | A potential metabolite of AB-CHMINACA in which the isopropyl group has bee… | 1 mg | 16453-1 | More Info |
| AB-CHMINACA metabolite M6 | A potential metabolite of AB-CHMINACA in which the isopropyl group has bee… | 5 mg | 16453-5 | More Info |
| AB-CHMINACA metabolite M6 | A potential metabolite of AB-CHMINACA in which the isopropyl group has bee… | 500 µg | 16453-500 | More Info |
CAYMAN CHEMICAL COMPANY
CAYMAN CHEMICAL COMPANY
1180 East Ellsworth Road
Ann Arbor MI 48108
P: (734) 971-3335
P: (800) 364-9897 (USA & Canada only)
F: (734) 971-3640
Customer Service: custserv@caymanchem.com
Technical Support: techserv@caymanchem.com
Sales: sales@caymanchem.com
http://www.caymanchem.com
Return to Profile